Cipla's Hamied, Poonawalla of Serum conferred awards

Cipla, ICICI Bank, Axis Bank, Tata Motors and Maruti Suzuki are top gainers in the Sensex. Among the losers are Dr Reddy's Labs, Coal India, Infosys, MM and Hindalco.

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

In a chat with ET Now, Prakash Diwan of Altamount Capital, shares his views on pharmaceutical stocks. ET Now: What about pure play pharmaceutical companies? Prakash Diwan: Cipla is good stock. The the pharma company has seen substantial ...

The revenue expected from exclusive sales of the Nexium generic in US is estimated at around $170 million. New Delhi: The US Food and Drug Administration (FDA) has permitted Teva Pharmaceuticals Industries Ltd to sell a generic version of ...

In a chat with ET Now, Prakash Diwan of Altamount Capital, shares his views on pharmaceutical stocks. ET Now: What about pure play pharmaceutical companies? Prakash Diwan: Cipla is good stock. The the pharma company has seen substantial ...

A file photo of the BSE building in Mumbai. Photo: Hemant Mishra/Mint Mumbai: US markets closed lower . S&P 500 lost 1.3% to 2,029 on weak earnings. Tracking the losses Asian markets opened in red. To improve competitiveness in various services ...

Private sector lenders Axis Bank, ICICI Bank and HDFC Bank were the predominant gainers on the BSE on Tuesday. However, pharma share Cipla led the pack with gains of 4.87 per cent. At 3 pm the share was trading at Rs 707.60 as against Rs 674.75 at ...

This page uses frames, but your browser doesn't

"We look for upside targets near the 9000 mark over the next few weeks. On stocks, we recommend buys on Cipla, IndusInd Bank, TCS, Coal India and Alstom India," says Gaurav Mehta, Ambit.